investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Events

2018 Oncologic Emergency Medicine Conference

8 Key Participants

2018 Oncologic Emergency Medicine Conference

January 25-26, 2018

The University of Texas MD Anderson Cancer Center
Dan L. Duncan Building (CPB), Floor 8, Rooms 1-8
1155 Pressler Street
Houston, Texas



This conference expects to provide current information on identifying oncologic emergencies, implementing best practices when treating cancer patients with emergencies, addressing the significance of palliative care in the patients presenting to the emergency department regarding symptom and pain management, discussing toxicities associated with standard cancer therapy and emerging novel cancer modalities, as well as addressing other topics that are critical to supporting and treating cancer patients.  Our conference aims to continue to fill knowledge gaps by providing information in an interactive forum that in turn enhances medical decision-making by healthcare providers.


Educational Objectives

After attending the conference, participants should be able to:

  • Identify emergent medical conditions (e.g. adverse events, symptoms, pain, etc.) that occur in cancer patients and demonstrate best practices to maximize quality of care within an emergency medicine environment (Knowledge, Competence, Performance, Patient Outcomes);
  • Provide supportive treatment pathways for cancer patients that experience complex symptoms that result in renal dysfunction, cardiac toxicities, tumor bleeding, pulmonary effusion, neutropenic fever, and acute infections (Knowledge, Competence, Performance, Patient Outcomes);
  • Continue to integrate palliative care skills into the framework of emergency medicine to patients with cancer (Knowledge, Competence);
  • Utilize the expertise of the oncologic emergency medicine clinicians and pharmacists to provide a better understanding of supportive care and pain management drugs in combination with chemotherapies (Knowledge, Competence, Performance, Patient Outcomes);
  • Identify and assess complications of stem cell transplant, especially graft vs. host disease (Knowledge)